AIG Hospitals to Launch ₹800 Crore Oncology Centre with South-East Asia’s First Dynamic ARC Proton Therapy

Qiagen Secures FDA Clearance for QIAstat-Dx Gastrointestinal Panel

Ovation.io Launches Groundbreaking GLP-1 Research Dataset to Advance Precision Medicine

Kotak Invests ₹940 Crore in Neuberg Diagnostics to Drive Expansion and IPO Preparation

NICE Recommends Olaparib for BRCA-Mutated Advanced Breast Cancer

SOPHiA GENETICS and Platomics Collaborate to Streamline IVDR Compliance for Clinical Labs

India Unveils Genome Sequencing Data of 10,000 Individuals: A Milestone in Biotechnology Research

Ambry Genetics Advances BRCA2 Variant Classification with CRISPR-Based Study Published in *Nature*

Geneoscopy Secures $105M Series C Funding to Advance Colorectal Cancer Screening

Vertex and Orna Partner to Develop In Vivo Gene Therapies for Blood Disorders

FDA Grants Priority Review to Dizal’s Sunvozertinib for EGFR Exon20ins NSCLC

MD Anderson and Myriad Genetics Forge Strategic Alliance to Advance MRD Testing in Cancer Care

Pillar Biosciences Partners with MSK to Enhance Precision Oncology with OncoKB™ Integration

CytoMed and SunAct Partner to Advance Allogeneic Gamma Delta T Cell Therapy in India

China’s NMPA Approves Astellas’ Zolbetuximab for Advanced Gastric and GEJ Cancer

Home
/
update
/
details

Qatar Precision Health Institute Unveils Genomic Data and Announces New Research Initiatives

NextEdge Admin

25 Oct 2024

2 min 45 sec

Qatar Foundation,Genomics,Precision medicine

The Qatar Precision Health Institute (QPHI), a research center under Qatar Foundation (QF), hosted a special event to unveil groundbreaking genomic data and announce new research initiatives. Held at QF’s headquarters, the event brought together key figures from Qatar’s healthcare and research sectors, including Sheikh Dr. Mohammed Al-Thani (MoPH), Dr. Khalid Fakhro (Sidra Medicine), Dr. Hilal Lashuel (QF), Dr. Ahmed Elmagarmid (QCRI), and Dr. Omar Albagha (QBRI).

Dr. Said Ismail, Acting President and Chief Scientific Operations Officer at QPHI, highlighted the release of Qatar’s largest genomic dataset, calling it a transformative step in precision health. “This data lays the foundation for groundbreaking research, positioning Qatar as a hub for genomics and translational medicine,” he stated.

The event showcased the 25,000 Genome Release, with QPHI’s Lead Bioinformatician, Dr. Chadi Saad, explaining how the dataset will accelerate research in cancer genetics, cardiovascular diseases, and mental health, utilizing advanced tools to reduce research costs and time. Dr. Eleni Fthenou introduced an updated data catalog designed to enhance access for researchers, fostering innovation through streamlined exploration and analysis.

Warehouse Specialist Sneha P. Chandran presented new tools enabling researchers to filter data by demographics, build cohorts, and conduct advanced analyses. Dr. Hamdi Mbarek, Director of Research and Partnerships, announced the second round of the Qatar Precision Health Research Consortium (QPHRC), focusing on genomics, AI, and strategic projects across multiple health fields.

Dr. Mbarek emphasized the importance of multi-institutional collaboration and capacity-building, inviting researchers to leverage genomic data for impactful discoveries. He thanked key partners, including MoPH, Sidra Medicine, Qatar University, and others, whose support drives QPHI’s vision of transforming healthcare through precision medicine, benefiting both Qatar and the global community.